Sigma Planning Corp Cyma Bay Therapeutics, Inc. Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$10.66 - $14.38 $327,262 - $441,466	-30,700 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$9.0 - $15.16 $30,600 - $51,544	3,400 Added 12.45%	30,700 $399,000
Q4 2017 Feb 07, 2018	BUY	$7.67 - $9.31 $94,341 - $114,513	12,300 Added 82.0%	27,300 $251,000
Q3 2017 Nov 06, 2017	BUY	$5.95 - $8.26 $89,250 - $123,900	15,000	15,000 $121,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.